Mucopolysaccharidosis Ii clinical trials

Explore recruiting mucopolysaccharidosis ii clinical trials.

Recruiting mucopolysaccharidosis ii studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Mucopolysaccharidosis Ii trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in Mucopolysaccharidosis Type II (Hunter Syndrome) Subjects

France, Spain, Germany, Poland, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

A PHASE III STUDY OF JR-141 IN MUCOPOLYSACCHARIDOSIS TYPE II (HUNTER SYNDROME) PATIENTS

Italy, Spain, Germany, Poland, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Mucopolysaccharidosis Ii trials by city

Mucopolysaccharidosis Ii in Toronto Mucopolysaccharidosis Ii in Vancouver Mucopolysaccharidosis Ii in Montreal Mucopolysaccharidosis Ii in Calgary Mucopolysaccharidosis Ii in Edmonton Mucopolysaccharidosis Ii in Ottawa Mucopolysaccharidosis Ii in Winnipeg Mucopolysaccharidosis Ii in Quebec City Mucopolysaccharidosis Ii in Hamilton Mucopolysaccharidosis Ii in Kitchener Mucopolysaccharidosis Ii in London Mucopolysaccharidosis Ii in Halifax Mucopolysaccharidosis Ii in New York Mucopolysaccharidosis Ii in Los Angeles Mucopolysaccharidosis Ii in Chicago Mucopolysaccharidosis Ii in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease